Original Research
Accepted on 31 Oct 2025
The oncometabolite R-2-hydroxyglutarate inhibits microglia activation via FTO/NF-B pathway
in Neuro-Oncology and Neurosurgical Oncology
Original Research
Accepted on 31 Oct 2025
in Neuro-Oncology and Neurosurgical Oncology
General Commentary
Accepted on 31 Oct 2025
in Molecular and Cellular Oncology
Review
Accepted on 31 Oct 2025
in Pediatric Oncology
Original Research
Accepted on 31 Oct 2025
in Cancer Epidemiology and Prevention
Original Research
Accepted on 31 Oct 2025
in Gynecological Oncology
Case Report
Accepted on 31 Oct 2025
in Radiation Oncology
Original Research
Accepted on 31 Oct 2025
in Radiation Oncology
Mini Review
Accepted on 31 Oct 2025
in Radiation Oncology
Case Report
Accepted on 31 Oct 2025
in Radiation Oncology
Original Research
Accepted on 31 Oct 2025
in Cancer Epidemiology and Prevention
Original Research
Accepted on 31 Oct 2025
in Molecular and Cellular Oncology
Correction
Accepted on 31 Oct 2025
in Gastrointestinal Cancers: Gastric and Esophageal Cancers
Original Research
Accepted on 31 Oct 2025
in Thoracic Oncology
Original Research
Accepted on 31 Oct 2025
in Head and Neck Cancer
Original Research
Accepted on 31 Oct 2025
in Cancer Immunity and Immunotherapy
Case Report
Accepted on 31 Oct 2025
in Surgical Oncology